Amsterdam, Netherlands

Tuna Mutis

USPTO Granted Patents = 5 

Average Co-Inventor Count = 11.1

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Tuna Mutis: Innovator in Antibody Therapeutics

Introduction

Tuna Mutis is a prominent inventor based in Amsterdam, Netherlands, known for his significant contributions to the field of antibody therapeutics. With a total of five patents to his name, he has made remarkable advancements in the treatment of cancer and other diseases through innovative antibody compositions.

Latest Patents

Tuna Mutis's latest patents include groundbreaking inventions such as bispecific anti-CD37 antibodies and monoclonal anti-CD37 antibodies. These inventions focus on CD37-specific bispecific antibody molecules that bind to different epitopes of the human CD37 antigen. The bispecific antibody molecules exhibit enhanced Fc-Fc interactions upon binding to CD37 on the cell surface. Additionally, his patents cover pharmaceutical compositions containing these molecules and their applications in treating cancer and other diseases. Another notable invention involves anti-CD37 antibodies with Fc-Fc interaction enhancing substitutions, used in combination with anti-CD20 antibodies for therapeutic purposes.

Career Highlights

Tuna Mutis is associated with Genmab Holding B.V., a leading biotechnology company specializing in the development of differentiated antibody therapeutics. His work at Genmab has positioned him as a key figure in the advancement of innovative cancer treatments.

Collaborations

Throughout his career, Tuna has collaborated with notable colleagues such as Simone Oostindie and Frank Beurskens. These collaborations have further enriched his research and development efforts in the field of antibody therapeutics.

Conclusion

Tuna Mutis stands out as an influential inventor in the realm of antibody therapeutics, with a focus on innovative solutions for cancer treatment. His contributions continue to shape the future of medical science and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…